Zoledronic acid increases the circulating soluble RANKL level in mice, with a further increase in lymphocyte-derived soluble RANKL in zoledronic acid- and glucocorticoid-treated mice stimulated with bacterial lipopolysaccharide
Keywords: ZA; zoledronic acid; BPs; bisphosphonates; sRANKL; soluble receptor activator of NF-kB ligand; OPG; osteoprotegerin; PBS; phosphate-buffered saline; PSL; prednisolone; LPS; lipopolysaccharide; ELISA; enzyme-linked immunosorbent assay; μCT; microfocus X-r